Vamsidhar Velcheti

Also affiliated with NYU Langone Health, Fulcrum Therapeutics (United States), Mayo Clinic in Arizona, Mayo Clinic in Florida, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

4.0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

Papers

Driven by 25 papers — median percentile 94. Top paper: “Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer”.

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer

npj Precision Oncology(2023)10.1038/s41698-023-00403-x

N/A

1.2DataRank · unranked

31 citations

Germán Corredor, Vidya Sankar Viswanathan, Ruiwen Ding, Paula Toro, Pingfu Fu +16 more

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

The Lancet Digital Health(2023)10.1016/s2589-7500(23)00082-1

N/A

0.708DataRank · unranked

111 citations

Lingzhi Hong, Muhammad Aminu, Natalie I. Vokes, Pingjun Chen, Morteza Salehjahromi +44 more

Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma

Modern Pathology(2023)10.1016/j.modpat.2023.100326

N/A

0.533DataRank · unranked

34 citations

Frank Rojas, Xin Hu, Alejandra G. Serrano, Bo Zhu, Hong Chen +23 more

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

Cancer Cell(2025)10.1016/j.ccell.2025.04.003

N/A

0.505DataRank · unranked

28 citations

Pingjun Chen, Muhammad Aminu, Jiànróng Lǐ, Junya Fujimoto, Yanhua Tian +47 more

Precision therapy for RET-altered cancers with RET inhibitors

Trends in cancer(2021)10.1016/j.trecan.2021.07.003

N/A

0DataRank · unranked

174 citations

Vamsidhar Velcheti, Blaine H. M. Mooers, Jie Wu, Vivek Subbiah, Kyaw Zin Thein

Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0543

N/A

0DataRank · unranked

40 citations

Alireza Khodadadi‐Jamayran, Igor Dolgalev, Hyunwoo Cho, Sana Badri, Luis Chiriboga +28 more

A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer

EBioMedicine(2021)10.1016/j.ebiom.2021.103481

N/A

0DataRank · unranked

29 citations

Kaustav Bera, Cristian Barrera, Yu Zhou, Cheng Lu, Pranjal Vaidya +8 more

Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004440

N/A

0DataRank · unranked

125 citations

Venkata Nagineni, Arvind Ravi, Ila Datar, Mari Mino–Kenudson, Germán Corredor +11 more

Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome

npj Precision Oncology(2022)10.1038/s41698-022-00277-5

N/A

0DataRank · unranked

49 citations

Prateek Prasanna, Germán Corredor, Cristian Barrera, Philipp Zens, Cheng Lu +14 more

Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.10.516003

N/A

0DataRank · unranked

3 citations

Hua Zhou, Nina Shenker-Tauris, Hortense Le, Theodore Sakellaropoulos, Nicolas Coudray +32 more

Density patterns of tumor-infiltrating lymphocytes and association with objective response to nivolumab in patients with lung adenocarcinoma from CheckMate 057.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2662

N/A

0DataRank · unranked

1 citations

Ruiwen Ding, Prateek Prasanna, Cristian Barrera, Paula Toro, Vidya Sankar Viswanathan +9 more

Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy

Cancer Research(2023)10.1158/0008-5472.can-23-2729

N/A

0DataRank · unranked

106 citations

Hsin‐Yi Huang, Ziyan Lin, Michela Ranieri, Shuai Li, Soumyadip Sahu +21 more

Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

Nature Communications(2023)10.1038/s41467-023-42327-x

N/A

0DataRank · unranked

29 citations

Hua Zhou, Nina Murrell, Hortense Le, Theodore Sakellaropoulos, Nicolas Coudray +35 more

Objective Analysis and Clinical Significance of the Spatial Tumor-Infiltrating Lymphocyte Patterns in Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2457

N/A

0DataRank · unranked

14 citations

Yvonne Wang, Gang Peng, Jianlei Gu, Mari Mino–Kenudson, Jonathan W. Riess +6 more

Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy

Cell Reports(2023)10.1016/j.celrep.2023.113016

N/A

0DataRank · unranked

8 citations

Kai Kang, Kwok Peng Ng, Tomas Radivoyevitch, Kurt A. Schalper, Zhang Hua +9 more

175P Radiomic biomarker of vessel tortuosity for monitoring treatment change: Preliminary findings in prospective evaluation of ECOG-ACRIN EA5163

Annals of Oncology(2023)10.1016/j.annonc.2023.09.2899

N/A

0DataRank · unranked

1 citations

Fenghai Duan, Vidya Sankar Viswanathan, Mohammadhadi Khorrami, Ning An, Vamsidhar Velcheti +7 more

In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1 -mutant lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.18.537350

N/A

0DataRank · unranked

1 citations

David H. Peng, David Fenyö, Hao Yuan, Alfonso Lopez, Daniel Levin +26 more

Computationally integrating radiology and pathology image features for predicting treatment benefit and outcome in lung cancer

npj Precision Oncology(2025)10.1038/s41698-025-00939-0

N/A

0DataRank · unranked

12 citations

Mohammadhadi Khorrami, Kaustav Bera, Pingfu Fu, Lukas Delasos, Amit Gupta +5 more

CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction

The Lancet Digital Health(2020)10.1016/s2589-7500(20)30002-9

N/A

0DataRank · unranked

133 citations

Kaustav Bera, Amit Gupta, Xiangxue Wang, Germán Corredor, Pingfu Fu +11 more

QVT Score, a radiomic biomarker of vascular complexity, enables prognostication and monitoring of NSCLC immunotherapy

medRxiv(2025)10.1101/2025.09.08.25335020

N/A

0DataRank · unranked

0 citations

Vamsidhar Velcheti, Kai Zhang, Amogh Hiremath, Liam Il‐Young Chung, Omid Haji Maghsoudi +15 more

Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001343

N/A

0DataRank · unranked

120 citations

Kaustav Bera, Pradnya D. Patil, Amit Gupta, Prantesh Jain, Mehdi Alilou +4 more

A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study

The Lancet Digital Health(2020)10.1016/s2589-7500(20)30225-9

N/A

0DataRank · unranked

81 citations

Kaustav Bera, Xiangxue Wang, Prateek Prasanna, Jun Xu, Andrew Janowczyk +12 more

Feature-driven local cell graph (FLocK): New computational pathology-based descriptors for prognosis of lung cancer and HPV status of oropharyngeal cancers

Medical Image Analysis(2020)10.1016/j.media.2020.101903

N/A

0DataRank · unranked

63 citations

Can Koyuncu, Germán Corredor, Prateek Prasanna, Patrick Leo, Xiangxue Wang +6 more

Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study

Lung Cancer(2020)10.1016/j.lungcan.2020.02.018

N/A

0DataRank · unranked

50 citations

Kaustav Bera, Patrick Leo, Pranjal Vaidya, Pradnya D. Patil, Rajat Thawani +12 more

Vamsidhar Velcheti

Indexed papers

Top data-sharing exemplar

Papers